AbbVie Inc.
NOVEL TRICYCLIC COMPOUNDS
Last updated:
Abstract:
The invention provides compounds of Formula (I) and Formula (II) ##STR00001## pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Status:
Application
Type:
Utility
Filling date:
13 Jun 2019
Issue date:
4 Mar 2021